Mastectomy Clinical Trials

Clinical trials related to Mastectomy Procedure

Randomized Controlled Trial of Postmastectomy Hypofractionated Radiotherapy Versus Conventional Fractionated Radiotherapy in Breast Cancer Patients Undergoing Prosthetic Breast Reconstruction

Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

This study investigates the safety and efficacy of hypofractionated radiotherapy (HFRT) versus conventional fractionated radiotherapy (CFRT) in breast cancer patients undergoing total mastectomy with prosthetic reconstruction. Study Design Population: Patients with high-risk breast cancer after mastectomy and immediate implant reconstruction. Intervention: HFRT Arm: 43.5 Gy in 15 fractions (2.9 Gy/fraction, 3 weeks). Control Arm: CFRT (50 Gy in 25 fractions, 2 Gy/fraction, 5 weeks). Endpoints Primary: Reconstruction failure rate (e.g., implant removal, capsular contracture)

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Female, aged 18-75 years

• Karnofsky Performance Status ≥60

• Histopathologically confirmed invasive breast adenocarcinoma

• Total mastectomy \[with or without nipple-areolar complex preservation\] + axillary dissection/sentinel lymph node biopsy + implant/expander placement R0 resection with negative margins

• pT3 or N2-3 disease; or pT1-2N1

• No distant metastasis

• Completed standard neoadjuvant/adjuvant chemotherapy cycles

• ≤8 weeks post-chemotherapy or ≤12 weeks post-surgery if no chemotherapy

• Signed informed consent

Locations
Other Locations
China
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
RECRUITING
Beijing
Contact Information
Primary
Xuran Zhao, MD
923791362@qq.com
86-13661135602
Backup
Yirui Zhai, MD
januarywind@163.com
86-18610168510
Time Frame
Start Date: 2026-03-27
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 506
Treatments
Experimental: HFRT group
43.5 Gy in 15 fractions (2.9 Gy/fraction, 3 weeks)
Other: CFRT group
50 Gy in 25 fractions, 2 Gy/fraction, 5 weeks
Related Therapeutic Areas
Sponsors
Leads: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

This content was sourced from clinicaltrials.gov

Similar Clinical Trials